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Abstract. In many neurodegenerative disorders that lead
to memory loss and dementia, the brain pathology respon-
sible for neuronal loss is marked by accumulations of pro-
teins in the form of extracellular plaques and intracellular
filamentous tangles, containing hyperphosphorylated cy-
toskeletal proteins. These are assumed to arise as a conse-
quence of deregulation of a normal pattern of topographic
phosphorylation—that is, an abnormal shift of cytoskeletal
protein phosphorylation from the normal axonal compart-
ment to cell bodies. Although decades of studies have been
directed to this problem, biochemical approaches in mam-
malian systems are limited: neurons are too small to permit
separation of cell body and axon compartments. Since the
pioneering studies of Hodgkin and Huxley on the giant fiber
system of the squid, however, the stellate ganglion and its
giant axons have been the focus of a large literature on the
physiology and biochemistry of neuron function. This re-
view concentrates on a host of studies in our laboratory and
others on the factors regulating compartment-specific patterns
of cytoskeletal protein phosphorylation (primarily neurofila-
ments) in an effort to establish a normal baseline of informa-
tion for further studies on neurodegeneration. On the basis of
these data, a model of topographic regulation is proposed that
offers several possibilities for further studies on potential sites
of deregulation that may lead to pathologies resembling those
seen in mammalian and human brains showing neurodegen-
eration, dementia, and neuronal cell death.
Introduction
Cephalopods are a remarkable group of animals with
large, complex brains that support a broad range of behav-
iors, including learning and memory. They exhibit many of
the neurobiological paradigms underlying mammalian
memory and learning. Octopods, for example, can be
trained to identify a variety of visual cues and can even
learn behaviorial tricks from one another such as opening
jars containing crab prey (Fiorito et al., 1990, Fiorito and
Scotto, 1992) Memory and learning can be impaired by
lesions to the vertical lobe of the octopus (Fiorito and
Chichery, 1995), but to date, no studies of endogenous
neurodegenerative disorders in squid or octopus have been
published. Nevertheless, cephalopod nervous systems have
served successfully for decades in our efforts to understand
the basic biology of normal nerve function, from the flow of
ion currents in the nerve impulse to the motor systems of
axon transport. This store of information acts as a baseline
for future research into the origin of the defective nerve
function and neuronal cell death responsible for memory
loss and dementia in neurodegenerative disorders.
The accumulation of tangles of highly phosphorylated,
filamentous cytoskeletal protein complexes in the cell bod-
ies of human brain or spinal cord neurons is a shared
pathological feature of many neurodegenerative disorders
such as Alzheimer’s disease and amyotrophic lateral scle-
rosis (Goedert, 1999; Fig. 1). Although the specific protein
inclusions vary with each disease, these large neuronal
aggregates may be responsible for neuron cell death and
loss associated with dementia and paralysis, respectively.
Among the culprit proteins are tau, neurofilaments,
synuclein, and huntingtin, which, through defects in their
metabolism, are abnormally processed and misfolded within
cell bodies into stable complexes together with kinases and
ubiquitins, among other proteins.
How such aggregates arise and how they contribute to
neuronal cell death has been the focus of decades of studies.
Biochemical, genetic, and molecular biological approaches
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have furnished an understanding of some of the factors
contributing to the pathology. One common thread emerg-
ing, however, has been the recognition that the normally
tight compartment-specific regulation of post-translational
processing (phosphorylation, glycosylation, etc.) and as-
sembly have been compromised in these disorders. For
example, neurofilaments, a major cytoskeletal component of
large axons, are normally assembled from subunit proteins
(NF-L, NF-M, and NF-H). Upon entry into the axon, the
latter two are highly phosphorylated in lysine-serine-proline
(KSP) repeats in their C-terminal tail domains (Sternberger
and Sternberger, 1983; Nixon et al., 1987, 1989; Pant et al.,
2000). This results in the formation of sidearms, cross-
bridges between NFs and microtubules, that create a cy-
toskeletal scaffold sustaining large axonal diameters (de
Waegh et al., 1992; Sanchez et al., 2000). Cell bodies, on
the other hand, contain only hypophosphorylated NF pro-
teins. Tail domain phosphorylation does not occur in cell
bodies except in pathological situations when KSP repeats
are hyperphosphorylated into filamentous aggregates. The
factors responsible for topographic regulation/deregulation
of NF phosphorylation are not understood, in part because
separation of cell bodies from axons in sufficient quantities
for biochemical studies is difficult in most mammalian
nervous systems. Fortunately, the stellate ganglion of the
squid giant fiber system, which shares many neuronal prop-
erties with mammalian systems, including a robust NF
metabolism, is readily separated into giant cell bodies and
pure axoplasm in quantities sufficient for diverse biochem-
ical studies. This system has been the focus of our studies
for several years as we attempted to sort out the factors
underlying the compartmental-specific patterns of neurofila-
ment phosphorylation.
The Squid Giant Fiber System
It was J. Z. Young who first described the structure and
origin of the giant fiber system of the squid Loligo (Young,
1939). Since then a vast literature on the physiology, be-
havior, and biochemistry of the giant fiber system has been
published, including the Nobel-prize-winning work of
Hodgkin and Huxley (see also, Gilbert et al., 1990). The jet
propulsion locomotory behavior of this remarkable organ-
ism depends upon the signaling evoked by a system of giant
neurons beginning with two large “command neurons” in
the brain. The command neurons integrate most sensory
input to transmit excitatory impulses to the dorsal stellate
ganglia and giant axons that innervate the muscles of the
mantle. The diameter of the giant axon can vary between
300 and 800 micrometers (Adelman and Gilbert, 1990), and
its length may extend several centimeters depending on
species and size of the animal. Accordingly, ganglia and
giant axons are easily dissected from the mantle and pre-
pared for electrophysiological and biochemical studies or
for studies of mechanisms of axon transport (Fig. 2). The
giant axon owes its large size to the fact that it arises as a
Figure 1. Example of aggregate expression in cervical spinal cord ganglion neurons in amyotrophic lateral
sclerosis (ALS). (A) Normal neuron. (B) Neuron showing ALS pathology as a result of deregulated topographic
neurofilament phosphorylation. Both expressing an antibody to phosphorylated NF-H.
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fusion of many individual axons from the large neurons
(25–40 m) of the giant fiber lobe (GFL). About 3–10 l of
pure axoplasm, uncontaminated by sheath or glial cells, can
be collected from a single giant axon, depending on size,
making it possible to collect up to 300–1000 l of axoplasm
from 10 squid (2 axons per squid). Together with GFL cell
bodies dissected from the same stellate ganglia, the two
tissue preparations can be compared biochemically. Using
this system, we have studied the factors regulating the
topographic phosphorylation of NF proteins.
Squid Neurofilament Proteins
Squid neurofilaments in the giant axon, like those in
mammalian axons, contribute to the large axon caliber re-
sponsible for rapid conduction velocity, a property essential
to the jet propulsive function of mantle muscle. Neurofila-
ments, together with microtubules and associated proteins,
are organized into a hexagonal array that makes up a three-
dimensional cytoskeletal network in the giant axon
(Metuzals and Izzard, 1969; Hodge and Adelman, 1980;
Martin et al., 1990). NFs make up about 13% of total
axoplasm protein (Brown and Lasek, 1990) and consist of
three subunit proteins—a large, highly phosphorylated NF-
220 and two smaller subunits, NF60 and NF70. These have
been cloned and shown to arise by alternative splicing from
a single gene, in contrast to the three independent genes that
code for mammalian NF subunits (Szaro et al., 1991; Way
et al., 1992). Biochemically and immunocytochemically,
the NF-220 is phosphorylated only in the axon, whereas a
non-phosphorylated NF-180, together with NF60/70, is de-
tected in the perikarya of the stellate ganglia (Tytell et al.,
1990; Cohen et al., 1987). Phosphorylation occurs predom-
inantly on the multiple K/RSP, SAR/K, and SEK/R repeat
sites (approximately 47) on the C-terminal tail of the NF-
220 subunit (Jaffe et al., 2001). This topographic pattern of
NF phosphorylation resembles that seen in mammalian neu-
rons, with the axon as the principal site of NF phosphory-
lation, as described above.
A comparison of kinase assays of axoplasm and GFL
lysates illustrates the differences in compartment activities.
Figure 2. Stellate ganglion and giant axon isolated from squid (Loligo pealei). (A) Intact preparation
showing giant axon (a) in its sheath and stellate ganglion (b) with stubs of other giant axons. About 2 normal
size. (B) Collection of pure axoplasm: (a) Droplet of axoplasm extruded from giant axon; (b) droplet squeezed
from axon, leaving empty collapsed sheath (c); (d) intact axon with sheath. (C) Isolated stellate ganglion showing
site of cut to collect giant fiber lobe cell bodies. “a” are giant axons.
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Western blot analysis of GFL and axoplasm lysates indicate
that, except for NF-220, cytoskeletal protein substrates are
indeed present in both compartments (Fig. 3) (Grant et al.,
1999). Although the protein expression profiles of axoplasm
and GFL are similar (Fig. 3A, left), the endogenous kinase
activity of axoplasm is significantly higher than in the GFL
(Table 1), with NF220 and other proteins highly phosphor-
ylated, as seen in the autoradiograph at the right of Figure
3A. The GFL lysate exhibits fewer phosphorylated proteins,
with most phosphorylation seen in low-molecular-weight
bands (asterisk). Although cell body tubulin is moderately
phosphorylated, the NF220 is not, in spite of the fact that the
overall phosphorylation activity is similar in both compart-
ments. Although this suggests that kinases are inactive
within cell bodies, equivalent phosphorylation of exogenous
substrates such as histone and casein (Fig. 3B, right, and
Table 1) indicates that kinases are indeed present and
equally active in the GFL lysate.
Significantly, however, endogenous higher molecular
weight proteins are much more robustly phosphorylated
within the axoplasm (Fig. 3A, right), suggesting that cell
bodies and axoplasm may not share the same set of kinases
and/or phosphatases.
Kinases in Axoplasm and GFL Are Similar
The multiple phosphate acceptor sites in NF proteins
invite a sequential pattern of phosphorylation by a number
of synergistically interacting kinases (Roach, 1991). In fact,
NF subunit proteins are phosphorylated at different ser/thr
sites within head and tail domains by a variety of kinases.
These include second-messenger-regulated kinases such as
PKA, PKC, and CAMKII (Sihag et al., 1988; Sihag and
Nixon, 1989; Dosemeci et al., 1990; Dosemeci and Pant,
1992), preferentially phosphorylating head domain sites;
second messenger independent kinases, CKI, CKII (Floyd
et al., 1991); GSK3 (Guidato et al., 1996) and proline-
directed kinases Erk1/2, JNK, SAPK, cdc-2, cdk5, among
others (Sun et al., 1996; Giasson and Mushynski, 1997;
Veeranna et al., 1998; Li et al., 1999). The C-terminal tail
domain KSP repeats in squid NF-H 220 are the principal
targets of phosphorylation by the proline-directed kinases.
A Western blot analysis of kinases expressed in GFL cell
bodies and axoplasm indicates that qualitatively at least, the
two compartments reveal a similar array of kinases (Grant et
al., 1999). Some kinases such as CKI are intimately bound
to the NF preparation extracted from axoplasm, suggesting
it may phosphorylate ser/thr sites in the glutamine-acid-rich
region of the NF tail domains and play an important role in
regulating axon transport (Floyd et al., 1991). Nevertheless,
both CKI and CKII are expressed in each compartment
(Grant et al., 1999). With respect to head-domain-specific
kinases, such as CAMKII and PKA, quantitative differences
have been demonstrated, with the cell body compartment
exhibiting significantly higher endogenous kinase activities.
These kinases phosphorylate specific NF head domain sites
that, when phosphorylated, prevent filament assembly
(Hisanaga and Hirokawa, 1990; Sihag and Nixon, 1989,
1990, 1991). The proline-directed kinases, cdc2-like (cdk5),
Erk1/2, GSK3, are also present at equal expression levels in
each compartment. Since no significant qualitative differ-
ences in the distribution of kinases are evident, how then
can we explain the profound difference in overall pattern of
endogenous protein phosphorylation between cell bodies
and axoplasm?
Axonal and Cell Body Multimeric Complexes of
Cytoskeletal Proteins and Kinases Are Different
To further explore topographic regulation of phosphory-
lation, the presence of a cdc2-like kinase in the squid giant
fiber system was investigated by P13 affinity chromatogra-
phy. P13, with a high binding affinity to cdc2 kinases, has
been used to extract cdc2 and associated proteins from
mitotic cells (Brizuela et al., 1987; Draetta et al., 1987). We
have used this procedure to study cdc2-like kinases in
axoplasm and cell body, which when combined with West-
ern blot analysis and kinase assays, will make it possible to
compare the P13 multimeric complexes characteristic of
each compartment (Takahashi et al., 1995; Grant et al.,
1999). Although NF220 was absent from the cell body
lysates, Western blots of each compartment were similar
with respect to other cytoskeletal proteins (tubulin, actin,
NF60/70) and a set of kinases. The P13 multimeric com-
plexes extracted from these lysates were dramatically dif-
ferent, however; the P13 axoplasm complex exhibited 6 to
20 times more endogenous and exogenous phosphorylation
activities (Fig. 4), contained more cytoskeletal proteins and
kinases, and expressed a qualitatively different cdc2-like
kinase epitope. The axonal multimeric complex, transported
in the growing squid axon, undergoes extensive phosphor-
ylation.
It is well established that most kinases (proline-directed
and non-proline-directed) copurify with their cytoskeletal
substrates as multimeric complexes. PKA, PKC, and CKI
copurify with NFs (Sihag et al., 1988; Floyd et al., 1991;
Dosemeci and Pant, 1992), while proline-directed kinases
such as cdk5 and Erk1/2 coassemble with NFs, tubulins, and
tau (Vallano et al., 1986; Veeranna et al., 2000). In cell
bodies, where cytoskeletal subunits and kinases are newly
synthesized, before secondary processing occurs, the mul-
timeric complexes assembled may differ significantly from
those assembling in the axon after the kinases and substrates
have been partially processed prior to transport. As a result,
the availability of phosphate acceptor sites, such as those on
C-terminal tail domains of NF proteins, may only become
accessible within the three-dimensional structure of a grow-
ing, stable axonal lattice. For example, although GFL and
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Figure 3. Comparison of kinase activities in lysates of axoplasm and giant fiber lobe (GFL). (A) Left,
Coomassie-stained gel showing similarity of protein expression in axoplasm and GFL, except for expression of
NF220 in axoplasm. Right, autoradiograph showing robust phosphorylation of proteins in axoplasm with
virtually no high-molecular-weight bands phosphorylated in GFL. Instead, there are high levels of phosphory-
lation at the advancing front (asterisk). (B) Left, Coomassie-stained gel showing protein profile in lysates
containing exogenous substrates histone and casein. Lane 1, axoplasm plus casein; lane 2, GFL plus casein; lane
3, axoplasm plus histone; lane 4, GFL plus histone. Note similarity in expression pattern. Right, autoradiograph
showing equivalent phosphorylation of exogenous substrates casein and histone by axoplasm (lanes 1 and 3) and
GFL (lanes 2 and 4), respectively. Even under these conditions, axoplasm reveals intense phosphorylation of
most proteins. HMW  high-molecular-weight. NFH 220 complex.
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axoplasm lysates expressed CKI and CKII, only the axonal
P13 complex expressed CKI, a result that correlated with its
high level of casein phosphorylation. This is consistent with
previous observations of the high affinity of CKI to the
axonal NF preparations and the possible role of CKI in
regulation of slow axonal transport of NFs. Moreover, elec-
tron microscopy studies of filamentous structures in cell
body and axoplasm reveal differences reflecting the phos-
phorylation-driven sidearm extension of the NF220 C-ter-
minal tail domains as NF polymers slowly migrate down the
axon (Cohen et al., 1987). The NF subunits predominate in
cell body NFs in a network of smooth filaments without
sidearms. In axoplasm, however, NFs exhibited a more
complex beaded structure arising from accumulations of
fixed phosphorylated NF220 sidearms associated with ki-
nases and other proteins.
Macromolecular complexes of kinases and scaffolding
proteins are common in signal transduction systems (Rob-
inson and Cobb, 1997), or in integrin-based focal adhesion
complexes (Miyamoto et al., 1995). Specific targeting pro-
teins, as part of such complexes, localize kinases to different
cellular compartments or organelles evoking activity (Faux
and Scott, 1996). A mammalian scaffold protein, AKAP79,
acts as a platform for the assembly of PKA, PKC, and
calcineurin, a complex that is targeted to neuronal postsyn-
aptic membranes where they colocalize with substrates
(Klauck et al., 1996).
Such localization mechanisms may account for the
perikaryal and axonal differences in phosphorylation activ-
ity characteristic of the squid giant fiber system. Does this,
however, fully explain topographic regulation? It may be a
partial answer, since the role of phosphatases in regulating
phosphorylation has not been explored.
Phosphatases as Regulators of Topographic
Phosphorylation
In an early study of kinase phosphorylation of squid NFs,
preliminary evidence was obtained suggesting that the low
level of endogenous NF phosphorylation by GFL extracts
was due to the presence of an active inhibitor. GFL extracts
added to an active axonal-derived NF preparation dramati-
cally inhibited phosphorylation (Pant et al., 1986). Heating
the GFL lysate eliminated the inhibitory effect, suggesting
that an enzyme—possibly a phosphatase—might be respon-
sible. Using phosphatase inhibitors, okadaic acid for the
ser/thr phosphatases, and vanadate for specific inhibition of
tyrosine phosphatases (Brautigan and Shriner, 1988; Gor-
don, 1991), phosphatase activities were compared in ex-
tracts from both compartments. Endogenous phosphoryla-
tion of GFL lysates was insensitive to okadaic treatment,
suggesting the relative inactivity of ser/thr phosphatases
(Grant and Pant, 2004). Surprisingly, ser/thr phosphatases
seem to be more abundant in axoplasm, suggesting that their
activities may be inhibited within the multimeric complex.
However, the response to vanadate points to the GFL cell
bodies as relatively enriched with tyrosine phosphatases and
tyrosine kinases compared to axoplasm, particularly those
associated with a membrane fraction. Localization of ty-
rosine kinases and phosphatases within membranes of the
cell body compartment may implicate signal transduction
pathways as additional negative regulators of cytoskeletal
protein phosphorylation. Western blot analysis, using mam-
malian-derived antibodies specific for catalytic groups on
mammalian and human phosphatase epitopes, did reveal
that the GFL membrane fraction expressed several tyrosine
phosphatases at higher levels together with tyrosine phos-
phatase assays (Grant and Pant, 2004) (Fig. 5). Can such
differences in tyrosine phosphatase activities account for
topographic regulation of phosphorylation? If so, how?
If we assume that the equilibria between kinase and
phosphatase activities within compartment-specific multi-
Figure 4. Autoradiographs showing a comparison of phosphorylation
activities in PI3 multimeric complexes extracted from axoplasm (lanes 1
and 3) and GFL, (lanes 2 and 4). Lane I, endogenous activity in axoplasm;
lane 2, endogenous activity in GFL; lane 3, PI3 axoplasm activity in the
presence of exogenous casein; lane 4, PI3 GFL activity in the presence of
casein. HMW  high molecular wt. NF220 complex.
Table 1
Comparison of total kinase activities (in pmol/g P  104) of
axoplasm and giant fiber lobe (GFL) lysates
Tissue End Hist Cas
AXO 10.2  3.7 11.6  3.8 6.0  6.0
GFL 5.9  3.1 15.2  4.9 12.6  10.0
Although endogenous activity of axoplasm is about 2 that in GFL, the
phosphorylation of exogenous substrates is about the same for histone and
casein in the GFL, suggesting that kinases are indeed present and active in
the GFL. End  endogenous activity; Hist  activity with histone as
substrate; Cas  activity with casein as substrate.
323GIANT AXON AND NEURODEGENERATION?
meric complexes are crucial to the endogenous patterns of
cytoskeletal protein phosphorylation, then changes in the
their respective three-dimensional configurations may facil-
itate shifts in equilibria and the accessibility of phosphate
acceptor sites. The occurrence of such structural changes is
suggested by the active phosphorylation response of axonal
extracts to changes in salt concentration while GFL extracts
remain unaffected (Fig 6). Endogenous kinase activity of
axonal extracts peaks at 100 mM salt, then declines at higher
salt concentrations. On the other hand, with an exogenous
substrate such as histone, no robust salt effect is noted in
axoplasm or in GFL extracts, suggesting that high salt
readily exposes acceptor sites on endogenous substrates in
the axonal multimeric complex. Or, on the other hand,
phosphatases may be more effectively dissociated from the
axoplasm complex in the presence of high salt, thereby
shifting the equilibria towards more active phosphorylation.
Because the nature of these complexes is unknown, we can
only conclude that the differential phosphorylation response
to salt corroborates the existence of compartment-specific
phosphorylation complexes.
Can the higher tyrosine phosphatase and tyrosine kinase
activities of the cell body membrane fraction provide an
alternative explanation for topographic regulation? Since
these enzymes target tyrosine sites rather than ser/thr sites,
it is unlikely that they directly affect substrate phosphory-
lation, but they may have some alternative regulatory role
that affects the activity of proline-directed kinases such as
cdc2, cdk5, and Erk1/2. These latter proline-directed ki-
nases phosphorylate the many KSP repeat motifs in the
C-terminal tail domain of the NF220. The absence of NF220
phosphorylation in cell bodies suggests that proline-directed
kinases may be down-regulated, perhaps by interaction with
signal transduction pathways. For example, kinases in the
MAP kinase signal transduction pathway, such as Erk1/2,
are activated by MEK1 phosphorylation at residues T183
and Y185, respectively, and inactivated by dephosphoryla-
tion by ser/thr phosphatases, tyrosine-specific phosphatases,
or dual-acting phosphatases (Cohen, 2000; Keyse, 2000).
The higher levels of tyrosine phosphatase activity in cell
bodies may inactivate Erk1/2 more effectively than in the
pure axoplasm. Alternatively, the higher tyrosine phospha-
tases in cell body membranes may down-regulate the recep-
tor signaling, thereby diminishing Erk1/2 activity. To in-
vestigate this possibility, we compared the expression of
activated Erk1/2 in GFL cell body lysates with axoplasm
lysates by Western blotting only to find, surprisingly, that
the pErk1/2 activities were similar (unpubl. data). Interpre-
tation of this result is difficult since activated Erk1/2 within
perikarya is probably segregated into separate nuclear and
cytoplasmic compartments, and only in the latter can it
associate with its cytoskeletal protein substrates. In pure
axoplasm, however, all activated Erk1/2 is cytoplasmic,
able to interact directly with all substrates. Further studies
are necessary to understand the relationship between the
MAP kinase pathway and its regulation by tyrosine phos-
phatases in cell bodies and axoplasm. It is noteworthy that
active MAP kinase in the axonal compartment seems to be
important in facilitating NF anterograde transport in cul-
tured neuroblastoma cells (Chan et al., 2004), raising the
possibility that C-terminal tail domain phosphorylation
drives NF transport. (See section on axon transport below.)
A Model of Topographic Regulation of NF Protein
Phosphorylation in the Squid Giant Fiber System
An appraisal of the above studies, including data from a
large literature on mammalian neurofilament phosphoryla-
tion, provides the basis for a working model of NF synthesis
and processing in the squid giant fiber system (Fig. 7).
Transcription and translational regulation of NF gene ex-
pression are not dealt with in the model; rather the focus is
Figure 5. Tyrosine phosphatase activities (specific activity) in mem-
brane fractions of whole axons and giant fiber lobe cell bodies, using a
specific phosphopeptide substrate and a Malachite green colormetric assay.
Cell body lystaes express significantly higher activities.
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on post-translational processing, NF assembly, and trans-
port from the cell body compartment to the axon. It is
assumed that all “players” in these processes—kinases,
phosphatases, regulators and cytoskeletal substrates—are
synthesized in cell bodies of the GFL, simultaneously with
the initial processing events. According to the model, po-
lymerization of NF monomers and oligomers is transiently
affected by phosphorylation of NF60-kd and NF 180-kd
head domain sites by PKA, PKC, or both. A cell-body-
specific multimeric complex of “incomplete” filaments and
dense bodies is assembled with little or no evidence of
sidearm formation (Cohen et al., 1987). The complex con-
sists of substrates; kinases, including proline-directed ki-
nases (Erk1/2, cdc2-like kinase, SAP kinase); and phospha-
Figure 6. Effect of varying concentrations of NaCl on endogenous kinase activities of axoplasm and giant
fiber lobe (GFL) extracts in the presence of phosphatase inhibitors. (A) Graph showing the response of axoplasm
extracts to increasing concentrations of NaCl, with peak activity at 100 mM, while GFL lysates exhibit no change
over the range of concentrations. (B) Autoradiograph of gels prepared from above lysates, showing the dramatic
differences in sensitivity of axoplasm and GFL extracts. Arrow points to low-molecular-weight region where
GFL activity is almost exclusively expressed. HMW  high-molecular-weight, NF220 complex.
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tases. Because of the three-dimensional configuration of the
complex, the numerous phosphate acceptor sites in the
C-terminal tail domain of NSF 180 are inaccessible to these
kinases. Accordingly, they are not phosphorylated. Further-
more, the higher levels of tyrosine phosphatase may also
contribute to an inactive complex by down-regulating the
activity of MAP kinases within the complex. Under these
conditions, the non-phosphorylated NFs readily associate
with microtubules within the axon initial segment for trans-
port within the axon. In this region, serine/thr phosphatases
are subsequently activated and NF head domain sites are
dephosphorylated, thereby promoting more stable polymer-
ization, changes in confirmation of the multimeric complex,
and exposure of tail domains to proline-directed kinases. As
polymeric NFs are slowly transported within the axon,
proline-directed kinases sequentially phosphorylate tail do-
main KSP repeat sites; this promotes further extension of
sidearms and crossbridge formation between NFs and mi-
crotubules, which assemble into a stable cytoskeletal core.
Inasmuch as the giant axons grow continuously throughout
the one-year life of the squid, axon growth is dynamic, with
a crossbridged cytoskeletal core moving slowly, if at all,
surrounded by more soluble tubulins and smaller moving
NF polymers that become integrated into the expanding
cytoskeleton (Galbraith et al., 1999). Sustaining this dy-
namic process of assembly and transport is a more robust
phosphorylation complex of active kinases and phospha-
tases to ensure continuous growth in length and diameter of
the underlying cytoskeletal network.
Very few details of this model have been experimentally
studied. One approach recently taken is to examine the role
of transient PKA head domain phosphorylation in the
Figure 7. Model of normal topographic regulation of neurofilament (NF) phosphorylation from cell body to
synaptic region. (1) Synthesis of NF monomers in cell body, coupled to head domain phosphorylation by PKA,
PKC, and/or CAMKII, and partial assembly with kinases and phosphatases into a relatively inactive multimeric
complex because of tyrosine phosphatase activity, and/or because specific motifs for proline-directed kinases are
inaccessible for phosphorylation by the 3-D configuration of the complex. (2) Axon hillock region in which
ser/thr phosphatases dephosphorylate NF head domains and promote NF assembly and association with
microtubule (motors?) to form an activated axon transport complex. (3) Within the axon complex, proline-
directed kinases (Erk1/2, SAPK, Cdc2-like kinases) along with CK1 and GSK3 progressively phosphorylate
newly accessible tail domain phosphate acceptor sites, including the numerous KSP repeats, resulting in sidearm
extension and formation of a stable cytoskeletal lattice. As the complex is slowly transported, small NF
oligomers are progressively added to the growing NF-core complex, where they are phosphorylated. (4) Finally,
at the axon tip near the synapse, ser/thr phosphatases are activated dephosphorylating tail domain sites, followed
by disassembly and degradation of the complex by calpains.
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Figure 8. Test of the model. Does PKA phosphorylation of specific serine sites in the head domain of NFM
inhibit phosphorylation of tail domain sites by proline-directed kinase Erk1/2? (A) Diagram of the sequence
structure of NF-M showing the C-terminal tail domain KSP sites for proline-directed kinases, the N-terminal
head domain PKA and PKC sites ser1, ser23, and ser46. The three serine sites were mutated to alanine
(muNFM), which prevents their phosphorylation. (B) NIH3T3 cells were transiently transfected with either
wild-type NF-M (wtNFM) or mutant NF-M and treated with EGF, which stimulates Erk1/2 activity and
phosphorylation of wt NF-M (lane 4), as seen with an antibody specific for tail domain phosphorylated KSP sites.
Prior stimulation of PKA kinase with forskolin (lane 2) inhibits NF-M phosphorylation without affecting Erk1/2
activity, suggesting that NF-M tail domain sites were made inaccessible by an intramolecular reconfiguration of
NF-M. Inhibition of PKA activity with a specific inhibitor (KT5720) restores NF-M tail domain phosphorylation
(lane 3). On the other hand, in response to EGF, cells transfected with the mutant NF-M exhibit levels of NF-M
tail domain phosphorylation similar to that seen in wtNF-M transfected cells (lane 6), and they are completely
unaffected by prior forskolin treatment and PKA activation; i.e., head domain sites are not phosphorylated (lane
5, compare to lane 2). Finally, activation of Erk1/2 is essential since an inhibitor of MEKI (PD98059), the
upstream kinase that activates Erk1/2, significantly down-regulates NF-M tail domain phosphorylation (lane 7).
(C) An immunocytochemical assay of the transfected cells using the same specific phosphorylated NF-M
antibody illustrates the effect. (a) Transfected 3T3 cells stimulated with EGF show robust expression of NF-M
tail domain phosphorylation. (b) Prior treatment of transfected cells with forskolin inhibits tail domain
phosphorylation. (c) Forskolin/EGF treated cells exposed to the PKA inhibitor KT5720 show normal NF-M tail
domain phosphorylation, while in (d), cells transfected with the muNF-M fail to respond to forskolin pretreat-
ment and express normal levels of NF-M tail domain phosphorylation.
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phosphorylation of KSP residues in C-terminal tail domains
of mammalian NF-M (Zheng et al., 2003). When cortical
neurons were treated with forskolin, which specifically ac-
tivates PKA phosphorylation, the phosphorylation of en-
dogenous NF-M tail domain was inhibited, as determined
by antibodies specific for the phosphorylated tail domain
epitopes (Fig. 8). Moreover, the sites of PKA phosphoryla-
tion were shown to be in the NFM head domain by trans-
fecting NIH3T3 cells with wild-type cells and NF-M mu-
tated at specific PKA head domain residues. Stimulation of
the cells expressing the mutant NF-M with epidermal
growth factor in the presence of forskolin failed to inhibit
NFM tail domain phosphorylation, but did inhibit tail do-
main phosphorylation in wild-type transfected cells. This
suggests an intramolecular model of inhibition; head do-
main phosphorylation, by preventing assembly of the NF
polymer from oligomers, evokes conformational changes in
tail domains such that they are inaccessible to proline-
directed kinases. Tail domains, in the absence of assembly,
may retain a globular, collapsed structure as seen in cell
body filaments. Such conformational changes could explain
the formation of an inactive, cell-body-specific multimeric
complex.
The mechanisms of slow and fast axon transport have
been extensively studied in the squid giant fiber system
(Weiss et al., 1990). Originally, it was believed that neuro-
filaments were transported as part of the slow transport
system, along with tubulin and actin. However, recent stud-
ies of green fluorescent protein (GFP)-labeled neurofila-
ments transfected into neurons or injected into axoplasm
have shown that axonal transport of neurofilaments is more
complex than previously assumed (Galbraith et al., 1999;
Prahlad et al., 2000; Wang et al., 2000; Yabe et al.,
2001a,b). Apparently, both NF-M and NF-H move at fast
rates followed by very long pauses, or by “fits and starts,”
giving the impression that most neurofilaments are station-
ary but a few move rapidly in bursts, in both directions.
Some studies suggest that neurofilaments move as poly-
mers, while others invoke smaller oligomers. To complicate
matters, rates of transport seem to relate to the extent of tail
domain phosphorylation in NF-M and NF-H (Yabe et al.,
2001b). C-terminal tail phosphorylation of NF-H and side-
arm formation seem to slow transport, but complete re-
moval of the NF-H tail domain in a transfected mouse
model had no apparent effect on axonal transport in the
optic nerve, nor on axonal caliber in motor and sensory
nerves (Rao et al., 2002). These contradictory results are
difficult to explain. In neurons without NF-H tail domains,
there is, however, a compensatory increase in phosphoryla-
tion of NF-M that may sustain the transport rate. We shall
see later that factors interfering with NF transport may be
responsible for some of the pathologies found in certain
neurodegenerative disorders.
Other features of the model, such as the role of phospha-
tases, are also under investigation. The complexity of the
processes involved in compartmental-specific phosphoryla-
tion implies a system of interactive networks with many
regulatory “nodes” at structural as well as molecular sites.
Any one of these might lead to deregulation and chronic
stimulation of cellular pathology, resulting in cell death.
Does the Model Offer Clues as to the Factors
Responsible for Some Forms of Neurodegeneration?
Squid, to our knowledge, do not suffer neurodegenera-
tion; perhaps they don’t live long enough. Nevertheless, the
giant axon of Loligo pealei has served as the generic model
of neural function in most organisms, and it is likely that the
underlying biochemical mechanisms are also shared. Does
the model described above offer any insights into the origin
of some neurodegenerative disorders that might inform a
working experimental approach?
For many neurodegenerative disorders, including Alzhei-
mer’s disease (AD), amyotrophic lateral sclerosis (ALS),
and Parkinson’s disease (PD), one of the principal neuronal
pathologies is the accumulation of abnormal aggregates and
neurofibrillary tangles within the cell body; these often
contain, among many other proteins, extensively phosphor-
ylated cytoskeletal proteins, such as PHF tau in AD and NFs
in ALS (Sternberger et al., 1985; Lee, 1995; Julien and
Mushynski, 1998; Al-Chalabi and Miller, 2003). Evidently
such accumulations are toxic to cells, which accounts for the
neuronal loss that leads to memory defects and dementia.
For decades, much effort has been directed to studying the
factors responsible for the abnormal phosphorylation and
aggregation of these elements within cell bodies. The results
of this effort, according to the model above, suggest that
topographic phosphorylation of cytoskeletal proteins has
been deregulated.
Can our studies on the squid axon, a large motor axon,
and its numerous cell bodies in the GFL provide any in-
sights into ALS pathology? In ALS, motor neurons with
somatal aggregates enriched in phosphorylated neurofila-
ments usually degenerate (see Fig. 1). The mechanisms
underlying this pathology and the factors responsible for
cell death have been intensively studied in a number of
model systems (Bruijn et al., 2004). A major lead was the
identification of several dominant mutations in the super-
oxide dismutase gene SOD1 responsible for familial-linked
ALS, which represents only 10% of all ALS cases (Rosen et
al., 1993; Sapp et al., 1995). The pathology and course of
the disease are similar to that seen in the majority of
sporadic ALS cases. The mutations result in a gain of toxic
properties leading to cell death. Transgenic mouse models
with these human SOD1 mutations gradually develop the
weakening disease and display the characteristic abnormal
motor neuron inclusions consisting of phosphorylated
NF-H, SOD1, and ubiquitin, among other proteins. How
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such stable aggregates induce neuronal death is not under-
stood, but the presence of ubiquitin suggests that abnormal
proteins are in the proteosome degradation pathway. Toxic
effects of such aggregates may clog proteosome pathways
with abnormal proteins, or they may alter mitochondrial
function, leading to apoptosis (Bruijn et al., 2004). It is not
clear whether the abnormal hyperphosphorylation of NF
within the cell body is the principal factor driving aggregate
formation, or whether abnormally phosphorylated proteins
result from conformational changes in the folding of sub-
strates within cell bodies (Kosik and Shimura, 2005). The
latter would suggest that exogenous stress factors (oxygen
radicals, excitatory stress factors, toxic substances produced
by the abnormal activity of the SOD1 mutant enzyme)
induce subtle modifications of a cell body’s multimeric
phosphorylation complex, activating kinases, inactivating
phosphatases, or both (Johnson et al., 1996). For example,
tyrosine phosphorylation of tau can induce significant con-
formational changes (Fabian et al., 1994). In the model, this
suggests that sites previously inaccessible to proline-di-
rected kinases such as cdc-2 like kinases (cdk5), and MAP
kinases, together with CK1, a non-proline-directed kinase
(Kuret et al., 1997), may become available for aberrant
hyperphosphorylation. It should be noted that abnormally
activated cdk5 kinase, a principal mammalian neuronal ki-
nase regulating a range of neuronal functions from migra-
tion during neurogenesis to mature synaptic function and
neuronal survival, has been implicated in tau hyperphos-
phorylation and tangle formation in AD (Patrick et al.,
1999). MAP kinase pathways, which are essential during
growth and differentiation in the developing nervous sys-
tem, may, when deregulated by stress, also lead to tau
hyperphosphorylation and cell death (Cheung and Slack,
2004; Subramaniam et al., 2004). Abnormal aggregates and
tangles found in perikarya of brain neurons in such disor-
ders as AD, Parkinson’s, or ALS are deregulated “multi-
meric” complexes of cytoskeletal proteins, active kinases
(Erk1/2, Cdk5, GSK3, PKA), other proteins (-synuclein),
and ubiquitin, suggesting that some abnormal proteins
within the complex are undergoing degradation (Pallares-
Trujillo et al., 1998).
Phosphorylated tangles and aggregates may hamper or
prevent axon transport of transmitter-filled vesicles to syn-
apses and induce cell death. It has been suggested that
highly phosphorylated NFs significantly slow axonal trans-
port: the more NF-H tail domain sites phosphorylated, the
greater the delay in transport (Ackerley et al., 2003, Jung et
al., 2000a,b). Moreover, two proline-directed kinases, im-
plicated as the principal players in NF-H C-terminal tail
domain phosphorylation in the squid giant axon, seem to
have conflicting effects on axonal transport in mammalian
neurons. On the one hand, cdk5 phosphorylation of NFs
seems to block axonal transport and induce the accumula-
tion of phosphorylated NFs within perikarya, presumably
by increased pausing during transport (Ackerley et al.,
2003; Shea et al., 2004). On the other hand, results from the
same laboratory indicate that NF C-terminal phosphoryla-
tion by MAP kinase (Erk1/2) facilitates and regulates ax-
onal transport (Chan et al., 2004). Each kinase seems to
have opposing effects on transport, perhaps indicating dif-
ferential effects on NF binding to the transport motors
kinesin and dynein, altering retrograde and anterograde
transport differentially. Nevertheless, the conundrum is fur-
ther complicated by observations, mentioned above, that
there were no effects on transport in axons transfected with
“tailess” NF-H mutant subunits (Rao et al., 2002).
Significantly, studies of axonal transport in axoplasm
extruded from the squid giant axon suggest that the effect of
cdk5 phosphorylation may be mediated indirectly by virtue
of its regulation of GSK3 activity and the kinesin motor
(Morfini et al., 2004). Sustained cdk5 activity is essential
for promoting kinesin-driven fast axon transport; specific
inhibition of cdk5 slows transport indirectly, by activating a
phosphatase PP1 that dephosphorylates and activates
GSK3, which in turn, phosphorylates the kinesin motor,
slowing anterograde but not retrograde transport. Since ki-
nesin is a motor responsible for the fast transport of NFs
(Yabe et al., 1999), such indirect effects on motors by
deregulated proline-directed kinases may contribute to the
perikaryal accumulation of aggregates by blocking axon
transport.
An alternative site for deregulation may be overexpres-
sion of one or another NF subunit precursor, or deletion of
an NF subunit as in NF null mice, thus disrupting subunit
stoichiometry, affecting NF assembly and axon diameter or
filament spacing (Elder et al., 1998; Rao et al., 1998; Zhu et
al., 1998). This, too, may alter the structure of phosphory-
lation complexes, activating kinases and NF phosphoryla-
tion, with subsequent effects on axon transport.
Finally, stress-induced abnormalities in signal transduc-
tion pathways that down-regulate ser/thr and/or tyrosine
phosphatases may disrupt the fine-tuned equilibria that
tightly regulate topographic phosphorylation between cell
body and axonal compartments. An increase in the number
of phosphorylated sites on cytoskeletal proteins within the
cell body could evoke conformational changes that result in
aggregates, tangles, obstructed transport, and eventually cell
death. Contrary to expectations, however, an increase of
assembled NF-M and NF-H in perikarya of SOD1 mutant
mice seems to ameliorate the disease, increasing life span
for many months (Couillard-Despres et al., 1998). In fact,
the perikaryal accumulations of hyperphosphorylated NF-H
induced by a deregulated cdk5 in SOD mutant ALS mice
alleviates the toxicity and improves the life span of the mice
(Nguyen et al., 2001), an unexpected result in view of the
presumed role of deregulated cdk5 and tau hyperphospho-
rylation in AD. It is proposed that the excess NF-H, with its
numerous KSP sites, acts as a sink for cdk5 activity, thereby
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reducing toxicity levels. This may, however, reflect only a
short-term adaptation since neurodegeneration is a long-
term process of accumulation of insults, so that an NF-H
sink may eventually become a burden if it is in the wrong
place. It is also possible that such conflicting results may
simply reflect differences in the affected neuronal pheno-
types—large motor neurons with very long, large-diameter,
myelinated axons compared to the smaller pyramidal neu-
rons of the cortex and hippocampus.
Another observation to confound our attempts to under-
stand ALS is the demonstration that the motor neuron
pathology in SOD mutant mice is not cell-autonomous but
seems to depend on interactions with surrounding cells,
perhaps other neurons or glia (Clement et al., 2003). When
chimeric mice that included both normal and SOD mutant
neurons in the same brain were used, those SOD1 neurons
that were surrounded by many normal non-neuronal cells
escaped the pathology and did not degenerate, while other
SOD1 neurons that were surrounded by mutant neurons or
nonneuronal neurons invariably degenerated. Such chimeric
mutant mice survived for much longer than the ALS model
mouse. Even more striking was the fact that normal neurons
surrounded by SOD1 mutant neurons developed the
perikaryal filamentous deposits and degenerated, evidently
“infected” by the abnormal neurons. At least in these model
ALS mice, glial interactions play an important role in the
development of the disease. In this connection, the squid
giant fiber system may offer an excellent opportunity to
study glial-axonal interactions because the axoplasm can be
readily separated from its glial-rich sheath, and both can be
studied biochemically under various experimental condi-
tions.
Such speculations serve primarily as working models for
further experimentation. Although we do not have squid
models for neurodegeneration, we do have the giant axon
system which, under appropriate experimental manipula-
tions, may be induced to undergo controlled pathologies
resembling those seen in neurodegenerative disorders.
These, in turn, might be more amenable to biochemical
studies.
It is noteworthy that another large motor neuron system,
that of the anterior bulbar cells (ABC cells) in the hindbrain
of the lamprey, a most primitive vertebrate, provides an-
other useful model for studying neuronal cytoskeletal reg-
ulation, particularly in experimentally induced neurodegen-
eration (Hall et al., 2000, 2001). The large ABC axons
resemble the squid giant axon in that they are not myelin-
ated. The principal, and only, NF subunit in the lamprey
neurons is NF-180, which is most homologous to mamma-
lian NF-M but has many more glutamic acid residues and
only two tail domain non-KSP phosphorylation sites. Nev-
ertheless, it forms NFs that function as they do in mamma-
lian neurons. Here, the effects of NF sidearm extension on
axon caliber are probably facilitated by the charge-charge
repulsions of the glutamic acid residues instead of highly
phosphorylated KSP sites. Compared to the squid giant
axon system, however, lamprey ABC neurons are more
amenable to experimental manipulation, such as direct cell
body injection of NF180 to study the effect of overexpres-
sion, or transfection of ABC cells by injection with GFP-
labeled human tau constructs to examine the time course of
tau-induced neural degeneration (Hall et al., 2001). For
example, in the latter study, the authors demonstrated that
the earliest stages of pathology were seen in swollen distal
dendrites of ABC neurons with accumulations of paired helical
filament (PHF1) antigen expression. In time, these accumula-
tions swept progressively into proximal dendrites, somata, and
axons, accompanied by tau hyperphosphorylation and degen-
eration. This study could provide some details of the progres-
sive stages of tau-induced neurodegeneration.
We see that these two unusual motor neuron systems—
squid giant fibers and lamprey ABC neurons—offer novel
experimental approaches to our efforts to understand neu-
rodegeneration: the former biochemically, because large
cell bodies can be separated from pure axoplasm; the latter
because of the ease of direct experimental manipulation by
transfection. It would be useful if the technology of the
latter could be successfully applied to the former.
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